A gene–dose effect is observed with this extra APP gene copy resulting in the generation of more amyloid beta (Aβ) in people with DS relative to their NT counterparts over their lifetime observed in post mortem data.8, 9. This evidence concerns the gene APP and Dravet syndrome.